Related Experiment Video
Updated: Sep 12, 2025

An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity
Published on: October 8, 2018
Genetic Control of tRNA-Derived Fragments Contributes to Cancer Risk
Bin Li1,2, Hanting Li1,2, Yan Li1,2
1Department of Epidemiology and Biostatistics, School of Public Health, State Key Laboratory of Metabolism and Regulation in Complex Organisms, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Abstract:
tRNA-derived fragments (tRF) are a class of small noncoding RNAs that have exhibited several functions in cancer. Recent studies have shown that mutations in tRNA genes can lead to global changes in tRF expression levels and may affect tRF function, highlighting the need to further elucidate the regulation and functions of tRFs in cancer. In this study, we conducted a pan-cancer analysis of tRF quantitative trait loci (tRFQTL), encompassing 16,703 genetic variants associated with tRF expression across 31 cancer types. A joint analysis of genome-wide association study data revealed that tRFQTLs were preferentially enriched in cancer risk loci and colocalized with 106 genome-wide association study variants, explaining a substantial portion of cancer heritability. Moreover, tRFs regulated by tRFQTLs were enriched in cancer-related pathways and correlated with drug response and immune infiltration. Notably, polygenic risk score models incorporating tRFQTLs improved high-risk population identification. Investigation of large-scale population cohorts revealed a tRFQTL, rs9461276, associated with colorectal cancer risk. In biological assays, the rs9461276-C allele increased tRF-18-HSQS52D2 expression, which suppressed colorectal cancer malignant phenotypes. Mechanistically, tRF-18-HSQS52D2 bound to the 3' untranslated region of POU2F1, destabilizing the oncogenic transcript. Integrated RNA sequencing and chromatin immunoprecipitation sequencing assays indicated that POU2F1 enhanced colorectal cancer cell proliferation by activating various pathologic pathways associated with oxidative and glycolytic metabolism, mitotic stability, and cell cycle regulation. Finally, a database (Cancer-tRFQTL) was generated as a resource to support investigation into tRF-mediated mechanisms and genetic basis of tRF expression in human cancers. Overall, this study helps advance the understanding of tRFs in cancer pathogenesis.
Significance:
Genetic variants modulating tRF expression significantly influence cancer risk, including rs9461276-C that upregulates tRF-18-HSQS52D2 to suppress its downstream oncogenic target POU2F1 and thereby inhibit colorectal cancer development. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI .
Insights
Genetic variants influencing transfer RNA-derived fragment (tRF) expression are linked to cancer risk and drug response. A specific tRF, tRF-18-HSQS52D2, suppresses colorectal cancer by targeting the oncogene POU2F1.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Transfer RNA-derived fragments (tRFs) are small non-coding RNAs with emerging roles in cancer.
- Mutations in tRNA genes can alter tRF expression and function, necessitating further investigation into tRF regulation in cancer.
Purpose of the Study:
- To conduct a pan-cancer analysis of tRF quantitative trait loci (tRFQTLs) to understand the genetic basis of tRF expression in cancer.
- To investigate the role of specific tRFs and their genetic regulators in cancer pathogenesis and drug response.
Main Methods:
- Pan-cancer analysis of 16,703 genetic variants associated with tRF expression across 31 cancer types.
- Joint analysis of GWAS data to identify colocalization between tRFQTLs and cancer risk loci.
- Biological assays, including RNA sequencing and ChIP-seq, to elucidate molecular mechanisms.
- Development of a comprehensive database (Cancer-tRFQTL).
Main Results:
- tRFQTLs are enriched in cancer risk loci and explain significant cancer heritability.
- tRFs regulated by tRFQTLs are involved in cancer-related pathways, drug response, and immune infiltration.
- A specific tRFQTL (rs9461276) is associated with colorectal cancer (CRC) risk, with its allele increasing tRF-18-HSQS52D2 expression.
- tRF-18-HSQS52D2 suppresses CRC phenotypes by targeting POU2F1, an oncogene that promotes proliferation via metabolic and cell cycle pathways.
Conclusions:
- Genetic variants influencing tRF expression play a significant role in cancer heritability and pathogenesis.
- tRFs, like tRF-18-HSQS52D2, represent potential therapeutic targets for cancer treatment.
- The Cancer-tRFQTL database provides a valuable resource for cancer genomics and tRF research.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
RNA Splicing

